Characteristics of interstitial lung disease in patients from post-marketing data on metastatic breast cancer patients who received abemaciclib in Japan

BACKGROUND: This study evaluated characteristics of patients treated with abemaciclib and diagnosed with interstitial lung disease (ILD), using 12-month post-marketing data from the real-world setting in Japan. METHODS: Spontaneous reports of adverse events in patients receiving abemaciclib were col...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yucherng, Noma, Satoshi, Taguchi, Yoshio, Takahashi, Masashi, Tsurutani, Junji, Mori, Shiho, Sakaguchi, Sachi, Asou, Hiroya, Tomii, Keisuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064939/
https://www.ncbi.nlm.nih.gov/pubmed/33453015
http://dx.doi.org/10.1007/s12282-020-01207-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064939/
https://www.ncbi.nlm.nih.gov/pubmed/33453015
http://dx.doi.org/10.1007/s12282-020-01207-8

Ejemplares similares